Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
RYTM.OQ - Rhythm Pharmaceuticals Inc
Rhythm Pharmaceuticals Inc to Discuss Interim Six-Month Phase 2 Results Evaluating Setmelanotide Call
Jun 13, 2026 / 01:00PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day everyone and thank you for standing by.
Welcome to Rhythm Pharmaceuticals results from phase two Praetor-W Willie syndrome trial.
At this time, all participants are in a listen-only mode.
After the speaker's temptation, there will be a question-and-answer session.
To ask a question, you will need to press star 11 on your telephone.
You will then hear a message advising your hand is raised to withdraw the question, please press 11 again.
Please be
Advised that today's conference is being recorded.
Now it's my pleasure to hand the conference to David Connolly with Investor relations at
Trustpilot
